Biomarin Pharmaceutical reported $-36494000 in Net Income for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -14.46M 29.41M
Acceleron Pharma XLRN:US $ -70.46M 6.94M
Agios Pharmaceuticals AGIO:US $ -88.77M 2.55M
Alexion Pharmaceuticals ALXN:US $ 636M 100.2M
Alnylam Pharmaceuticals ALNY:US $ -204.51M 14.96M
Amgen AMGN:US $ 1884M 1420M
Arena Pharmaceuticals ARNA:US $ -196.31M 50.22M
Bayer BAYN:GR € 85M 2420M
Biogen BIIB:US $ 329.2M 119.3M
Biomarin Pharmaceutical BMRN:US $ -36.49M 49.44M
Bluebird Bio BLUE:US $ -216.82M 24.89M
Gilead Sciences GILD:US $ 2592M 1070M
Gw Pharmaceuticals GWPH:US $ -19.68M 9.47M
Insmed INSM:US $ -112714000 4.61M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
IONIS PHARMACEUT IONS:US $ -82M 1.12M
Moderna Inc MRNA:US 3.33B 553M
Neurocrine Biosciences NBIX:US $ 22.5M 19.8M
Ptc Therapeutics PTCT:US $ -133.62M 15.25M
Puma Biotechnology PBYI:US $ -44.67M 39.57M
Regeneron Pharmaceuticals REGN:US $ 1632.2M 1466.7M
Sangamo Biosciences SGMO:US $ -47.69M 0.52M
Sarepta Therapeutics SRPT:US $ -48.14M 33.26M
Seattle Genetics SGEN:US $ -293.85M 209.27M
Ultragenyx Pharmaceutical RARE:US $ -73M 49.43M
United Therapeutics UTHR:US $ 162.7M 9.9M
Vertex Pharmaceuticals VRTX:US $ 851.93M 785M
YTE INCY:US $ 181.74M 32.28M